BTC Capital Management Inc. Has $1.36 Million Stock Holdings in Sanofi (NASDAQ:SNY)

BTC Capital Management Inc. trimmed its stake in shares of Sanofi (NASDAQ:SNY) by 1.5% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 28,229 shares of the company’s stock after selling 434 shares during the quarter. BTC Capital Management Inc.’s holdings in Sanofi were worth $1,361,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in SNY. Synergy Asset Management LLC acquired a new position in shares of Sanofi during the fourth quarter worth $25,000. Northwest Investment Counselors LLC acquired a new position in shares of Sanofi in the third quarter worth approximately $29,000. Concord Wealth Partners boosted its holdings in Sanofi by 157.8% in the third quarter. Concord Wealth Partners now owns 593 shares of the company’s stock valued at $34,000 after acquiring an additional 363 shares during the last quarter. Fortitude Family Office LLC raised its stake in Sanofi by 708.6% during the third quarter. Fortitude Family Office LLC now owns 752 shares of the company’s stock worth $43,000 after buying an additional 659 shares during the last quarter. Finally, Sunbelt Securities Inc. raised its position in shares of Sanofi by 72.1% in the 3rd quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock worth $43,000 after acquiring an additional 313 shares in the last quarter. 14.04% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the company. StockNews.com downgraded Sanofi from a “buy” rating to a “hold” rating in a research note on Thursday, December 12th. Deutsche Bank Aktiengesellschaft raised shares of Sanofi from a “sell” rating to a “hold” rating in a research report on Thursday. Two analysts have rated the stock with a hold rating, one has issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $60.00.

Sanofi Stock Performance

Shares of SNY opened at $54.15 on Friday. Sanofi has a 1 year low of $45.22 and a 1 year high of $58.97. The stock’s fifty day moving average price is $49.12 and its two-hundred day moving average price is $52.24. The firm has a market cap of $137.42 billion, a PE ratio of 27.63, a PEG ratio of 1.21 and a beta of 0.57. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.00 and a quick ratio of 0.65.

Sanofi (NASDAQ:SNY) last posted its earnings results on Thursday, January 30th. The company reported $0.70 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.70. Sanofi had a return on equity of 27.45% and a net margin of 9.96%. On average, equities research analysts forecast that Sanofi will post 3.82 EPS for the current year.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.